AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

2019 Post-ESMO Report - ResearchAndMarkets.com

November 21, 2019

DUBLIN--(BUSINESS WIRE)--Nov 21, 2019--

The “2019 Post-ESMO Report” has been added to ResearchAndMarkets.com’s offering.

2019 Post-ESMO Report features summaries of a few key topics along with commentary from analysts on specific presentations. It also includes a compilation of all data events added in conjunction with the meeting.

Drug Abstracts Covered

Biliary Tract Cancer

Bladder Cancer

Breast Cancer

Colorectal Cancer

Oesophagal Cancer

Gastric Cancer

Head & Neck Cancer

Non-Small Cell Lung Cancer (NSCLC)

Ovarian Cancer

Prostate Cancer

Renal Cell Cancer (RCC)

Solid Tumors

Thyroid Cancer

For more information about this report visit https://www.researchandmarkets.com/r/dsfm55

View source version on businesswire.com:https://www.businesswire.com/news/home/20191121005780/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: PHARMACEUTICAL HEALTH ONCOLOGY

SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 11/21/2019 12:02 PM/DISC: 11/21/2019 12:02 PM

http://www.businesswire.com/news/home/20191121005780/en